MorphoSys AG buy Maxi_Scalibusa
Summary
This prediction ended on 30.05.12 with a price of €16.98. The price of MorphoSys AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.45%. Maxi_Scalibusa has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -1.476% | -1.476% | 262.181% | -16.395% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by Maxi_Scalibusa for this prediction
In the thread Morphosys AG diskutieren
seit Jahren die 18-20 Euro
Die Aktie kämpft nun schon seit Jahren mit dem Widerstandsbereich um 18-20 Euro. Da die Rückläufer aber immer kürzer werden und nun schon wieder ein Anlauf ansteht ist der Chart sehr interessant. Hier sollte bald ein schwungvoller Ausbruch nach oben kommen, damit die Aktie die lange schmale Zone verlässt. Da dies meist sehr dynamisch und schnell gehen kann ist dies eine spekulative Empfehlung auf dieses Szenario.